banner
LightNews
fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO
@fumikochino.bsky.social
3.6K followers 210 following 610 posts

#RadOnc. Reformed Artist. Cancer Widow. I study #FinancialToxicity #Access #Equity MD Anderson Cancer Center 📲me COI http://bit.ly/3OBu0Cn 🐦🪶🕊️ #medSky #oncSky migration

Videos
Economics 64%
Public Health 16%
Posts Media Videos Starter Packs
Pinned
fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · Dec 8
"For both patients and providers, prior authorization can feel like an unfair game they are designed to lose."

Honored to work w/ Dr @nathangray.bsky.social on a graphic op-ed out now @usatoday.com on how #PriorAuth can leave some patients literally dying in pain.

www.usatoday.com/story/opinio...
For patients and doctors, insurance prior authorization can be a dangerous game | Opinion
Doctors trying to get patients necessary drugs and procedures stymied by health insurance prior authorization. It's not a game. It's life and death.
www.usatoday.com
6 46 100

fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 4h
Good morning Chicago! Excited for Day 1 of @ASCO #ASCOQLTY25
Downtown Chicago at dawn
1 6

Reposted by Cary P. Gross

fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 5h
I am honored to give the #ASCOQLTY25 Simone Award to @drrobinyabroff.bsky.social today. Dr Yabroff has a profound impact as a researcher, policy advocate, & mentor. It's hard to find someone in health services research that hasn't been positively influenced by her intellect, wit, & warmth.🏆
ASCO JOSEPH SIMONE QUALITY CARE AWARD Robin Yabroff, PhD, MBA, FASCO American Cancer Society
2 8

fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 21h
On my way to Chicago for @ascocancer.bsky.social #ASCOQLTY25!! This year's meeting is filled with science, innovation, & fellowship.

🧐I may be biased but I think it's the best program yet!

Same day registration still possible or join us remotely 💻 & you won't miss a thing! www.asco.org/quality
A women in a black and white dress, glasses and a KN95 mask on an airplane
1 7

fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 2d
“Cancer pts & their families are being pulled into the #priorauthorization process, at the expense of their time, health, & well-being”
 
#Priorauth isn’t just an administrative hurdle for clinicians; it’s a hidden 2nd job for patients. #ascoQLTY25

@ascocancer.bsky.social
@ascopost.bsky.social
Prior Authorization Is Burdensome for Patients, Resulting in Treatment Delays, Financial Strain, and Stress
“This study makes clear what many of us in oncology have suspected: Prior authorization isn’t just an administrative hurdle for clinicians; it’s a hidden second job for patients,” noted investigators....
ascopost.com
4 7

Reposted by Cary P. Gross

fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 2d
New in @medpagetoday.com: Financial side effects from #breastcancer treatment can create life-altering problems, including distress, debt, & employment disruptions #bcsm #financialToxicity

Proud of the work of @mdanderson.bsky.social PGY5 Dr Kamaria Lee in the @ascocancer.bsky.social
#ASCOEdBook
Kamaria Lee and Fumiko Chino on Financial Toxicity and Breast Cancer
Still needed: interventions at government, institutional, and provider levels
www.medpagetoday.com
2 2

Reposted by Bridgette Thom

fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 3d
#Priorauthorization #UtilizationManagement for costly 2nd-line 💊 is understandable but nearly one-half of plans have quantity limits for generic ondansetron, a cheap ($16 for 60 8mg tabs) & effective 1st-line drug

Make this make sense.
 
#fixPriorAuth
@michaelannica.bsky.social
@jamanetworkopen.com
Prior Authorization, Quantity Limits, and Step Therapy for Antiemetics
This cross-sectional study evaluates whether antiemetic drugs for patients with cancer who have Patient Protection and Affordable Care Act (ACA) Marketplace or Medicaid plans are subject to utilizatio...
jamanetwork.com
2 3

fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 3d
The 2025 @ascocancer.bsky.social Quality Care Symposium #ASCOQLTY25 will feature >600 abstract presentations covering the latest implementation science and the entire spectrum of health services research.

📖 Review abstracts today!
✈️ Join us this weekend in Chicago

meetings.asco.org/abstracts-pr...
#ASCOQLTY25 Abstracts Now Available Explore more than 600 abstracts spanning the entire spectrum of health services research from distinguished leaders in quality care. View Abstracts
2 5

fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 4d
Kirby claw machine win 🏆 #weekendsinHouston
A woman holding a Kirby plushie who is wearing a bunny costume in a claw machine room with a man playing a game in the background.
3

fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 5d
Francis Bacon, Gary Larson, and Neil

#weekendsinHouston
Neil in front of a famous Francis Bacon of a blurry man struggling with a door. Neil is miming pushing a door The famous Gary Larson Farside comic of a kid trying to push a door marked pull
5

fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 7d
Any day I get to talk to Dr Monty Pal is a good day... even better when we get to discuss the amazing science being presented at @ascocancer.bsky.social #ASCOQLTY25!

There is still time to register and join us in Chicago next weekend Oct 10-11, 2025.
👉 www.asco.org/quality/regi...
Two people with headsets recording a podcast
1 6

fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 8d
Great work by a @mdanderson.bsky.social fellow on this @ascocancer.bsky.social 📄:
 
Lutetium-177-PSMA-617 #Lu177 #PSMA is a targeted tx option for use in metastatic castration-resistant #prostatecancer #mCRPC #pcsm. Access to #Lu177PSMA is limited by financial, logistical, & geographic barriers.
Access to Lu177-PSMA for Prostate Cancer: From Clinical Trials to the Real World
Lutetium-177-PSMA-617 is a new therapeutic modality approved for select patients with advanced prostate cancer. Many patients face access barriers because of travel burden, cost, and other logistic co...
dailynews.ascopubs.org
1 4

fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 9d
🧦 🥰🥰🥰
1

fumikochino.bsky.social
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 9d
Phenomenal #ASTRO25 session yesterday about #AYACSM dx, tx, and survivorship concerns. I was proud to be on stage with a community doc, academic researcher, psych-oncologist, and #AYAC survivor, caregiver, and Director of an oncosurvivorship PCP clinic. @astro-org.bsky.social
5 people standing in front of a screen, 4 physicians, one psyD
1 4